Ipamorelin

Ipamorelin 

Ipamorelin is a highly selective pentapeptide that functions as a growth hormone secretagogue (GHS). It is widely used in scientific studies examining pathways related to growth hormone (GH) release, pituitary signaling, and ghrelin‑receptor interactions. As a selective agonist of the GHS‑R1a receptor, Ipamorelin has become a leading compound for researchers exploring targeted GH modulation.

Unlike earlier GH secretagogues, Ipamorelin demonstrates high receptor selectivity, which allows researchers to study GH‑related pathways with reduced influence on other hormonal systems. Its selectivity distinguishes it from broader‑acting secretagogues such as GHRP‑6 or GHRP‑2.

Researchers commonly utilize Ipamorelin to investigate:

• Mechanisms of GHS‑R1a receptor activation
• Pituitary GH release signaling pathways
• Interactions between ghrelin‑mimetic peptides and endocrine regulation
• Dose‑dependent GH secretion profiles in vivo and in vitro
• Comparative potency and selectivity among GHS peptide classes
• Peptide stability, purity, and pharmacokinetic behavior

Scientific interest also extends to Ipamorelin’s minimal impact on cortisol and prolactin, which allows researchers to analyze GH‑specific effects without broader endocrine stimulation.

Important Note: Ipamorelin is intended for research purposes only and should not be used for human consumption or self-administration. Always ensure compliance with local regulations when handling peptides.